QRH-882260

N/A

Report date: 2025/08/21 20:00:08
NME

Base Information

Drug NameQRH-882260
Drug Alias NameQRH-882260
ClassificationDiagnostic agent (In vivo)Small molecules > Synthetic peptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsPositron-emission tomography enhancers
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MichiganUniversity Of Washington
Active IndicationsN/A
Inactive IndicationsCholangiocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A